Embody, Inc. — Department of Defense SBIR Phase I: AF212-CSO1
Embody, Inc. — SBIR Phase I award from Department of Defense.
- Amount
- $49,768
- Agency
- Department of Defense · Air Force
- Program / Phase
- SBIR · Phase I
- Topic
- AF212-CSO1
- Solicitation
- X21.2
- NAICS
- —
- Place of performance
- VA
- Period
- 2021-10-29 → 2022-02-07
Description
Embody, Inc. has pioneered a breakthrough, scalable, and robust biomanufacturing approach producing musculoskeletal tissue-like constructs to improve the treatment, recovery rate, and regeneration of commonly injured muscles, ligaments, and tendons among